newsfilter
← Latest News
GlobeNewswire·

NIH to Evaluate Iclaprim Activity against Listeria

NEW YORK, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/Nasdaq: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that the...